New things learned: BLA Timeline - Clinical Secti
Post# of 148294
(Total Views: 350)
Posted On: 12/17/2019 4:26:47 PM
New things learned:
BLA Timeline - Clinical Section - Deep discussions most likely 700mg dose
CNC Section - Providing this by end of month
January timeline
____________________________________________________________
mTNBC - First patient - 4th draw - Still no metastasis - Responding to Leronlimab
Under compassionate use - Quite a number of new people
Phaseb 1-2 - 4 patients this month
Licensing agreements
- NASH - Sent results to large pharmaceuticals - in talks with many large pharmaceuticals
- Cancer - Multiple pharmaceuticals - All over the world
- HIV Prevention - Signed a memorandum of understanding 1200 patients - once a month prevention
- MS study - Autoimmune disease - EAE in SJL Mice - Tested Leronlimab after 1st symptoms of paralysis injected - Half of the mice reduced times of paralysis, other half did not become re-paralyzed.
- Leronlimab is highly effective in humans over mice
- Possible phase 2 for MS right away.
Licensing agreement
Cytodyn - SIGNED AGREEMENT!!!
Vierra Pharmaceuticals - Could not understand
87.5 million dollars
4 million dollars in common stock
BLA Timeline - Clinical Section - Deep discussions most likely 700mg dose
CNC Section - Providing this by end of month
January timeline
____________________________________________________________
mTNBC - First patient - 4th draw - Still no metastasis - Responding to Leronlimab
Under compassionate use - Quite a number of new people
Phaseb 1-2 - 4 patients this month
Licensing agreements
- NASH - Sent results to large pharmaceuticals - in talks with many large pharmaceuticals
- Cancer - Multiple pharmaceuticals - All over the world
- HIV Prevention - Signed a memorandum of understanding 1200 patients - once a month prevention
- MS study - Autoimmune disease - EAE in SJL Mice - Tested Leronlimab after 1st symptoms of paralysis injected - Half of the mice reduced times of paralysis, other half did not become re-paralyzed.
- Leronlimab is highly effective in humans over mice
- Possible phase 2 for MS right away.
Licensing agreement
Cytodyn - SIGNED AGREEMENT!!!
Vierra Pharmaceuticals - Could not understand
87.5 million dollars
4 million dollars in common stock
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼